250 Fifthly, in recital 387 of the contested decision, the Commission emphasised the fact that, in an email sent to Arrow on 15 January 2002, Cipla stated that it was ready to support Arrow in any litigation with Lundbeck, although it wished to provide the necessary information concerning its process directly to the competent authorities, and not first to Arrow or to Tiefenbacher.
Serumkalium:In een groot placebogecontroleerd klinisch onderzoek wogen bij vele patiënten de tegengestelde effecten van aliskiren (# mg of # mg) en hydrochloorthiazide (# mg of # mg) op de kaliumspiegel in serum ongeveer tegen elkaar opEurLex-2 EurLex-2